Generated by All in One SEO Pro v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# Gameto

Redefining women's health

## Sitemaps

- [XML Sitemap](https://dev-gametogen.pantheonsite.io/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Register Interest in Fertilo](https://dev-gametogen.pantheonsite.io/register-interest-in-fertilo/) - See if You're Eligible for the US Study Is Fertilo Available in my Country? Sign up to Receive Updates on Fertilo

## Pages

- [Home](https://dev-gametogen.pantheonsite.io/) - Breaking Barriers in Women's Health with Gameto's Biotechnology Innovations. Explore how we are transforming fertility treatments and menopause care.
- [For Clinics](https://dev-gametogen.pantheonsite.io/for-clinics/) - Use Fertilo at Your Clinic Join the growing list of clinics using Fertilo to improve IVF and egg freezing. Fertilo has not been approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. Register Interest Accessible for patients and clinics Quick and easy integration into clinic workstreams. Fertilo effectively matures immature eggs
- [Home-Draft-FertiloSections](https://dev-gametogen.pantheonsite.io/home-page-draft-for-fertilo-section/) - Engineering the future of reproductive health. Despite a growing infertility crisis, reproductive health has received limited focus and investment. Gameto is working on groundbreaking solutions that put women and families first. Find a Fertilo Clinic First Baby Born Using iPSC Technology Gameto's iPSC-derived technology is designed to dramatically improve IVF and is showing promise in
- [Careers](https://dev-gametogen.pantheonsite.io/careers/) - Seeking Biotech Revolutionaries Our mission to redefine women's health requires a committed team of intelligent, daring, and diverse individuals. Open Roles Life at Gameto Our team is mission-driven, kind, collaborative, and authentic. We are determined to use scientific breakthroughs to create products people love. Our team is united by our shared mission as we work
- [Company](https://dev-gametogen.pantheonsite.io/company/) - Redefining women’s health with innovative solutions We believe novel advances in the fertility industry will improve and modernize the entire female reproductive journey. Bruna Paulsen, PhD VP of Manufacturing at Gameto, IVF Mom Dusan Perovic Gameto Investor and BOD Member, IVF Dad Martin Varsavsky Serial Entrepreneur, Gameto Co-founder and Chairman, IVF Dad Mark Johnson Stem
- [Fertilo Updates](https://dev-gametogen.pantheonsite.io/fertilo-updates/) - Stay Updated on Fertilo Register your interest to receive the latest news on Fertilo, including commercial availability in your area.
- [Fertilo](https://dev-gametogen.pantheonsite.io/science/fertilo/) - Lessening the hormonal burden of fertility treatments on women: Fertilo. Current fertility treatments are hard on women physically, professionally, and financially Physically: Women are subject to ~two weeks of hormonal injections, which can cause complications, side effects, and ovarian hyperstimulation syndrome.Professionally: Women often miss work and everyday activities due to frequent clinic visits and medical
- [Ameno](https://dev-gametogen.pantheonsite.io/science/ameno/) - Combating the negative effects of menopause with science: Ameno. Menopause severely impacts quality of life. Despite the fact that over 1 billion women will experience menopause by 2025, few effective treatments exist. In addition to debilitating symptoms, menopause is associated with an increased risk of numerous conditions, including osteoporosis, dementia, depression, heart disease, and Alzheimer’s
- [Pipeline](https://dev-gametogen.pantheonsite.io/pipeline/) - Gameto's Pipeline. Our team of engineers is using this platform to build a portfolio of treatments for women’s health. Pipeline See clinicaltrials.gov for Gameto’s Human Pregnancy/Live Birth (Phase 3) Fertilo in Vitro Research Study and Trial (FIRST) trial. Animal Studies Human Egg Maturation Human Embryo Formation Human Pregnancy/Live Birth (Phase 3) Clinically Available Fertilo Improve
- [Is Fertilo Available in My Country](https://dev-gametogen.pantheonsite.io/is-fertilo-available-in-my-country/) - Find a Fertilo Clinic Fertilo is currently being investigated in a Phase 3 clinical trial and is not approved for marketing in the United States. Fertilo will be evaluated for safety and effectiveness as part of this Phase 3 study. Fertilo is currently available in Australia, Argentina, Peru, and Mexico. Select Country Australia Mexico Peru
- [For Women and Families](https://dev-gametogen.pantheonsite.io/for-women-and-families/) - Fertilo: The Future of IVF and Egg Freezing Gameto is on a mission to study ways to improve the IVF and egg freezing process by reducing the burden on women and families. Where is Fertilo Available? Fertilo Has Been Designed to Enable Rapid Egg Maturation Outside the Body Fertilo is a solution aimed at reducing
- [For Partners](https://dev-gametogen.pantheonsite.io/for-partners/) - We are open to strategic partnerships that will advance the state of women's health globally Gameto is on a mission to improve women's health and rapidly expand access. Partner with Us Join us. Latest News News December 31, 2025 A company is trying to unlock a key to aging, in a long-overlooked body part Read
- [Science](https://dev-gametogen.pantheonsite.io/science/) - Advancing Reproductive Health Technologies Using breakthrough cell engineering technology, Gameto is developing an ecosystem of therapeutics to support women and families through their reproductive journeys. Explore Our Pipeline Women's reproductive health hasn't changed much in 40 years Egg freezing and IVF protocols still rely on technology developed in the 1970s. Ovarian disease remains severely understudied.
- [Opt-out preferences](https://dev-gametogen.pantheonsite.io/opt-out-preferences/)
- [Contact](https://dev-gametogen.pantheonsite.io/contact/) - Contact Us Fertilo for Clinics Read about how Fertilo can easily integrate into your clinic workstreams. For Clinics Learn More About Fertilo​ Read about how Fertilo can improve your IVF or egg freezing process. For Patients Want access to Fertilo where you live? Join our email list! We’ll keep you updated as we expand to
- [Deovo](https://dev-gametogen.pantheonsite.io/science/deovo/) - A truly novel approach to studying women's biology and health: Deovo. Many of today’s drugs have not been tested in women. Clinical trials have only been required to include women since 1993. Many products used today are understudied in women, leading to severe side effects and low efficacy.Diseases of the female reproductive system are understudied
- [Terms of Service](https://dev-gametogen.pantheonsite.io/terms-of-service/) - 1. Acceptance of Terms Gameto, Inc. (referred to as “Company,” “us” or “we”), provides the website (http://gametogen.com) and associated websites (collectively referred to as the “Site”), subject to your compliance with the following Terms and Conditions of Use (“Terms”), as well as any other written agreement(s) between us and you. We reserve the right to change these Terms from time
- [Privacy Policy](https://dev-gametogen.pantheonsite.io/privacy-policy/) - At Gameto, Inc. (referred to as “Company,” “us” or “we”), we recognize that your privacy is important. This Policy discloses the privacy practices for the Company’s Websites (collectively, the “Site”). This Policy also covers how personal and other information that we receive or collect about you is treated. Please read the information below to learn
- [Mexico](https://dev-gametogen.pantheonsite.io/fertilo-mexico/)
- [Peru](https://dev-gametogen.pantheonsite.io/fertilo-peru/)
- [Australia](https://dev-gametogen.pantheonsite.io/fertilo-australia/)
- [Fertilo](https://dev-gametogen.pantheonsite.io/fertilo/) - Fertilo Product Overview Current fertility treatments are hard on women physically, professionally, and financially Physically: Women are subject to ~two weeks of hormonal injections, which can cause complications, side effects, and ovarian hyperstimulation syndrome.Professionally: Women often miss work and everyday activities due to frequent clinic visits and medical side effects.Financially: IVF is expensive. The average woman must go

## Job Openings

- [Vice President of Accounting](https://dev-gametogen.pantheonsite.io/careers/vice-president-of-accounting/) - About the Role Gameto is seeking a Vice President of Accounting to lead the company’s accounting function as we grow as a clinical- and commercial-stage biotechnology company. This role will be responsible for overseeing all aspects of accounting operations, financial reporting, and internal controls, while serving as a key partner to the CEO, VP of
- [Associate, CEO Office](https://dev-gametogen.pantheonsite.io/careers/associate-ceo-office/) - About the Role Gameto is seeking an Associate to the CEO office to partner closely with the leadership team on high-priority strategic, financial, and operational initiatives partnering across investor relations, business development, and scientific teams. This is a fast-paced, high-impact role ideal for someone with 1–3 years of investment banking or management consulting experience who
- [Interested in Working at Gameto?](https://dev-gametogen.pantheonsite.io/careers/interested-in-working-at-gameto/) - If you're interested in working with Gameto but can't find a job opening at the moment, please share your resume with us at careers@gametogen.com. We may reach out about future opportunities! About Gameto: Gameto is a pioneering biotechnology company in women’s health, co-founded by Dina Radenkovic, a physician-turned-entrepreneur, and Martin Varsavsky, a leader in fertility
- [Medical Director](https://dev-gametogen.pantheonsite.io/careers/medical-director/) - About the job Medical Director of Global Clinical Operations – Women’s Health & Reproductive Medicine Location: Spain, EU Salary Range: $90,000-$120,000 plus bonuses Position Summary We are seeking a strategic, dynamic, and highly organized Medical Director of Global Clinical Operations to lead and manage international clinical studies focused on our IVF/IVM product Fertilo. This role

## Newsroom

- [Gameto Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health](https://dev-gametogen.pantheonsite.io/news/gameto-selected-to-receive-10-million-award-from-arpa-hs-sprint-for-womens-health/) - Funding will be Used to Accelerate Research for Menopause Program, Ameno
- [Gameto to Showcase Innovative Therapies at ASRM 2025: Advancing Menopause Treatment and Embryology Solutions](https://dev-gametogen.pantheonsite.io/news/gameto-to-showcase-innovative-therapies-at-asrm-2025-advancing-menopause-treatment-and-embryology-solutions/) - Gameto, a biotechnology company developing transformative solutions in women’s reproductive healthcare, will be presenting at the 2025 annual meeting of the American Society for Reproductive Medicine (ASRM). The company will present a series of exclusive talks and interactive sessions, including an oral presentation on Gameto’s new ovarian implant therapy for menopause, a Fertilo embryology demonstration,
- [Gameto Selected for Seven Presentations at the American Society for Reproductive Medicine (ASRM) 2024 Annual Meeting](https://dev-gametogen.pantheonsite.io/news/gameto-selected-for-seven-presentations-at-the-american-society-for-reproductive-medicine-asrm-2024-annual-meeting/) - NEW YORK, October 8th, 2024 — Gameto, a biotechnology company dedicated to advancing treatment options in women’s health and reproductive longevity, today announced the company was selected to give seven presentations at the American Society for Reproductive Medicine (ASRM) 2024 Annual Meeting, the largest reproductive medicine conference in the United States. Gameto’s presentations highlight progress
- [Gameto Appoints Dr. Jaime Knopman as Chairwoman of Clinical Advisory Board to Guide Clinical Strategy and Innovation in Women’s Health](https://dev-gametogen.pantheonsite.io/news/gameto-appoints-dr-jaime-knopman-as-chairwoman-of-clinical-advisory-board/) - NEW YORK, September 30th, 2024 — Gameto, a biotechnology company dedicated to advancing treatment options in women’s health and reproductive longevity, is pleased to announce the appointment of Dr. Jaime Knopman as Chairwoman of its Clinical Advisory Board. In this key role, Dr. Knopman will provide strategic leadership and guidance on company programs, working closely
- [Gameto Appoints Dr. Ghassan (Gus) Haddad as Chief Medical Officer to Lead Clinical Development of Fertilo, a Cell-Based Treatment for IVF and Egg Freezing](https://dev-gametogen.pantheonsite.io/news/gameto-appoints-dr-ghassan-gus-haddad-as-chief-medical-officer-to-lead-clinical-development-of-fertilo-a-cell-based-treatment-for-ivf-and-egg-freezing/) - NEW YORK, September 9th, 2024 — Gameto, a biotechnology company dedicated to advancing treatment options in women’s health and reproductive longevity, today announced the appointment of Dr. Ghassan (Gus) Haddad as Chief Medical Officer (CMO). ‍ Dr. Gus Haddad received his medical degree from the American University of Beirut, and has completed his Residency in
- [Gameto CEO Dr. Dina Turner Recognized Among the Most Exceptional Entrepreneurs at the Goldman Sachs 2023 Builders and Innovators Summit](https://dev-gametogen.pantheonsite.io/news/gameto-ceo-dr-dina-turner-recognized-among-the-most-exceptional-entrepreneurs-at-the-goldman-sachs-2023-builders-and-innovators-summit/) - NEW YORK, Oct. 18, 2023 /PRNewswire/ -- Gameto, a female-led biotechnology company with a mission to redefine women's healthcare, announced today that Goldman Sachs is recognizing Gameto CEO and Co-Founder Dr. Dina Turner as one of the Most Exceptional Entrepreneurs of 2023 at its Builders and Innovators Summit in Healdsburg, California. Goldman Sachs selected Dr.
- [Gameto Unveils New Data on In Vitro Maturation Product Candidate Fertilo During Four Presentations at the 2023 American Society for Reproductive Medicine](https://dev-gametogen.pantheonsite.io/news/https-www-prnewswire-com-news-releases-gameto-unveils-new-data-on-in-vitro-maturation-product-candidate-fertilo-during-four-presentations-at-the-2023-american-society-for-reproductive-medicine-3019616/) - Gameto's findings show their product candidate, Fertilo, is able to improve egg maturation and embryo development in shortened human minimal stimulation cycles. The group reports healthy animal live births with Fertilo, more mature human eggs with better gene expression and genetic health quality, as well as a potential use case in rescuing immature human eggs from conventional treatments. The combined findings are an important evidence package as a next step in advancing this reproductive technology.
- [Gameto Presents Data Supporting Manufacturing Process for its In Vitro Maturation Solution for Fertility Care at 2024 International Society for Stem Cell Research Annual Meeting](https://dev-gametogen.pantheonsite.io/news/gameto-presents-data-supporting-manufacturing-process-for-its-in-vitro-maturation-solution-for-fertility-care-at-2024-international-society-for-stem-cell-research-annual-meeting/) - Research demonstrates Gameto's modifications to the manufacturing process resulted in ovarian support cells of improved reproducibility, purity and efficacy for in vitro maturation applications Novel approach represents first clinical translation of clinical-grade hiPSCs to potentially enhance IVF outcomes and advance solutions for women’s health
- [REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs](https://dev-gametogen.pantheonsite.io/news/reprocell-announces-license-agreement-with-gameto-for-the-advancement-of-its-program-to-improve-assisted-fertility-using-ipscs/) - Gameto plans to use the iPSC line to advance its program, Fertilo, designed to improve IVF and egg freezing.
- [Gameto Named as 2023 Technology Pioneer by World Economic Forum](https://dev-gametogen.pantheonsite.io/news/gameto-named-as-2023-technology-pioneer-by-world-economic-forum/) - Gameto is ranked in the top 100 most promising Technology Pioneers for its work improving women's reproductive health
- [Gameto Expands Executive Team with the Addition of Teri Loxam as Chief Financial Officer](https://dev-gametogen.pantheonsite.io/news/gameto-expands-executive-team-with-the-addition-of-teri-loxam-as-chief-financial-officer/) - NEW YORK, April 28, 2023 /PRNewswire/ -- Gameto, a female-led biotech company developing therapies to improve the female reproductive journey, today announced the expansion of its executive team with the appointment of Teri Loxam as its first Chief Financial Officer. In this new role, Teri will oversee Gameto's financial function, as well as play a
- [A company is trying to unlock a key to aging, in a long-overlooked body part](https://dev-gametogen.pantheonsite.io/news/a-company-is-trying-to-unlock-a-key-to-aging-in-a-long-overlooked-body-part/)
- [I’m the first woman in Australia to become pregnant this way](https://dev-gametogen.pantheonsite.io/news/im-the-first-woman-in-australia-to-become-pregnant-this-way/)
- [A Sydney woman is the first in Australia to fall pregnant using a new 'gentler' IVF technique.](https://dev-gametogen.pantheonsite.io/news/a-sydney-woman-is-the-first-in-australia-to-fall-pregnant-using-a-new-gentler-ivf-technique/)
- ['People Thought It Was Insane': How Startup Gameto Is Turning Women's Health Sci-Fi Into Reality](https://dev-gametogen.pantheonsite.io/news/people-thought-it-was-insane-how-startup-gameto-is-turning-womens-health-sci-fi-into-reality/)
- [In Conversation with Dina Radenkovic Turner, Gameto’s CEO and Co-Founder](https://dev-gametogen.pantheonsite.io/news/in-conversation-with-dina-radenkovic-turner-gametos-ceo-and-co-founder/)
- [Gameto Licenses Foundational Meiosis IP to Advance Human Ovary-in-a-Dish Platform](https://dev-gametogen.pantheonsite.io/news/gameto-licenses-foundational-meiosis-ip-to-advance-human-ovary-in-a-dish-platform/)
- [The quest to make babies with lab-grown eggs and sperm](https://dev-gametogen.pantheonsite.io/news/the-quest-to-make-babies-with-lab-grown-eggs-and-sperm/)
- [Introducing BioSpace's 2025 40 Under 40 Winners: Dr. Dina Radenkovic](https://dev-gametogen.pantheonsite.io/news/introducing-biospaces-2025-40-under-40-winners-dr-dina-radenkovic/)
- [Gameto to Present at 43rd Annual J.P. Morgan Healthcare Conference](https://dev-gametogen.pantheonsite.io/news/gameto-to-present-at-43rd-annual-j-p-morgan-healthcare-conference/)
- [Gameto's $44M Series C to Help Redefine Reproductive Care, as First Patients Recruited for Pivotal Stem Cell Phase 3 Trial](https://dev-gametogen.pantheonsite.io/news/gametos-44m-series-c-to-help-redefine-reproductive-care-as-first-patients-recruited-for-pivotal-stem-cell-phase-3-trial/)
- [New IVF protocol offered in Texas provides hope to families](https://dev-gametogen.pantheonsite.io/news/new-ivf-protocol-offered-in-texas-provides-hope-to-families/)
- [MIT Technology Review Innovators Under 35: Christian Kramme, PhD](https://dev-gametogen.pantheonsite.io/news/mit-technology-review-innovators-under-35-christian-kramme-phd/)
- [ABJ Women in Business Awards 2025: Dr. Dina Radenkovic](https://dev-gametogen.pantheonsite.io/news/abj-women-in-business-awards-2025-dr-dina-radenkovic/)
- [Dr. Dina Radenkovic takes us to the future](https://dev-gametogen.pantheonsite.io/news/dr-dina-radenkovic-takes-us-to-the-future/)
- [Gameto Raises $44 Million for Stem Cell IVF Therapy](https://dev-gametogen.pantheonsite.io/news/gameto-raises-44-million-for-stem-cell-ivf-therapy/)
- [IVF Reborn: Engineered Ovarian Cells for Maturing Eggs Reach Final Test](https://dev-gametogen.pantheonsite.io/news/ivf-reborn-engineered-ovarian-cells-for-maturing-eggs-reach-final-test/)
- [Gameto lands $44m to advance fertility and menopause programs](https://dev-gametogen.pantheonsite.io/news/gameto-lands-44m-to-advance-fertility-and-menopause-programs/)
- [Fertility startup Gameto raises $44M to fund Phase 3 study of stem cell IVF therapy](https://dev-gametogen.pantheonsite.io/news/fertility-startup-gameto-raises-44m-to-fund-phase-3-study-of-stem-cell-ivf-therapy/)
- [Gameto Raises $44M Series C as Stem Cell IVF Therapy Enters Phase 3 Trial](https://dev-gametogen.pantheonsite.io/news/gameto-raises-44m-series-c-as-stem-cell-ivf-therapy-enters-phase-3-trial/)
- [Fertility Startup Gameto Raises $44M to Test Egg-Freezing Therapy in US](https://dev-gametogen.pantheonsite.io/news/fertility-startup-gameto-raises-44m-to-test-egg-freezing-therapy-in-us/)
- [New cheaper and less gruelling IVF technique being trialled in Sydney](https://dev-gametogen.pantheonsite.io/news/new-cheaper-and-less-gruelling-ivf-technique-being-trialled-in-sydney/)
- [Gameto Announces First U.S. Clinical Site Open for Enrollment in Fertilo Study](https://dev-gametogen.pantheonsite.io/news/gameto-announces-first-u-s-clinical-site-open-for-enrollment-in-fertilo-study/)
- [Gameto Announces Landmark Pregnancy Rate for iPSC-Derived Fertilo, Achieving More Than Double the Success Rate of Standard IVM](https://dev-gametogen.pantheonsite.io/news/gameto-announces-landmark-pregnancy-rate-for-ipsc-derived-fertilo-achieving-more-than-double-the-success-rate-of-standard-ivm/) - AUSTIN, Texas--(BUSINESS WIRE)--Gameto, a clinical-stage biotech company developing iPSC-based therapies to transform fertility care, announced today positive data from a 40-patient cohort demonstrating the efficacy of its lead product, Fertilo. The evaluation showed that Fertilo, which uses lab-engineered ovarian support cells (OSCs) derived from human-induced pluripotent stem cells (iPSCs), significantly enhances in vitro maturation (IVM)
- [Gameto Reports Positive Results for IVF Alternative Technology That Reduces Hormone Treatments](https://dev-gametogen.pantheonsite.io/news/gameto-reports-positive-results-for-ivf-alternative-technology-that-reduces-hormone-treatments/)
- [An IVF Alternative Could Make Having Babies Less Onerous](https://dev-gametogen.pantheonsite.io/news/an-ivf-alternative-could-make-having-babies-less-onerous/)
- [Live from Nasdaq Marketsite with Gameto](https://dev-gametogen.pantheonsite.io/news/live-from-nasdaq-marketsite-with-gameto/)
- [Most Effective Strategies to Close the Innovation Gap in Women's Health](https://dev-gametogen.pantheonsite.io/news/most-effective-strategies-to-close-the-innovation-gap-in-womens-health/)
- [Fertilo in Vitro Research Study and Trial (FIRST)](https://dev-gametogen.pantheonsite.io/news/fertilo-in-vitro-research-study-and-trial-first/)
- [Fertility treatments, closer to becoming cheaper?](https://dev-gametogen.pantheonsite.io/news/fertility-treatments-closer-to-becoming-cheaper/)
- [Nature Is Sexist. Can Advances In Longevity Biotechnology Help Restore Reproductive Equality?](https://dev-gametogen.pantheonsite.io/news/nature-is-sexist-can-advances-in-longevity-biotechnology-help-restore-reproductive-equality-copy/)
- [Gameto Awarded $10M ARPA-H Funding](https://dev-gametogen.pantheonsite.io/news/gameto-awarded-10m-arpa-h-funding/)
- [This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF](https://dev-gametogen.pantheonsite.io/news/this-biotech-could-one-day-make-human-eggs-from-scratch-but-first-theyre-trying-to-rethink-ivf/)
- [Gameto CEO Dina Radenkovic talks about running a women's health biotech, the development of Fertilo, work on menopause, and more](https://dev-gametogen.pantheonsite.io/news/gameto-ceo-dina-radenkovic-talks-about-running-a-womens-health-biotech-the-development-of-fertilo-work-on-menopause-and-more/)
- [This biotech CEO decided to take her own (fertility) medicine](https://dev-gametogen.pantheonsite.io/news/this-biotech-ceo-decided-to-take-her-own-fertility-medicine/)
- [Gameto Secures $33M in Series B Funding to Advance Novel In Vitro Fertilization Treatments](https://dev-gametogen.pantheonsite.io/news/gameto-secures-33m-in-series-b-funding-to-advance-novel-in-vitro-fertilization-treatments/)
- [The next frontier in baby-making: More successful IVF, egg cells from men, and sperm cells from women? Biotech researchers aim to greatly expand reproductive opportunity.](https://dev-gametogen.pantheonsite.io/news/the-next-frontier-in-baby-making-more-successful-ivf-egg-cells-from-men-and-sperm-cells-from-women-biotech-researchers-aim-to-greatly-expand-reproductive-opportunity/)
- [The Future of Fertility: A new crop of biotech startups want to revolutionize human reproduction.](https://dev-gametogen.pantheonsite.io/news/the-future-of-fertility/)
- [Gameto Raises $33 Million in Series B Financing to Advance Development and Commercialization of Novel Fertility Treatments](https://dev-gametogen.pantheonsite.io/news/gameto-raises-33-million-in-series-b-financing-to-advance-development-and-commercialization-of-novel-fertility-treatments/)
- [The 20(+1) under 40: Your guide to the next generation of biotech leaders](https://dev-gametogen.pantheonsite.io/news/the-20-1-under-40-your-guide-to-the-next-generation-of-biotech-leaders/)
- [Gameto Announces World’s First Live Birth Using Fertilo Procedure that Matures Eggs Outside the Body](https://dev-gametogen.pantheonsite.io/news/gameto-announces-worlds-first-live-birth-using-fertilo-procedure-that-matures-eggs-outside-the-body/)
- [Gameto Announces Patient Experience Data Demonstrating Investigational In Vitro Maturation Solution Well Tolerated with Higher Patient Satisfaction Rates than Conventional Fertility Stimulation](https://dev-gametogen.pantheonsite.io/news/gameto-announces-patient-experience-data-demonstrating-investigational-in-vitro-maturation-solution-well-tolerated-with-higher-patient-satisfaction-rates-than-conventional-fertility-stimulation/)
- [Reimagining Infertility – An Interview with Christian Kramme](https://dev-gametogen.pantheonsite.io/news/reimagining-infertility-an-interview-with-christian-kramme/)
- [Gameto Partners with Designer and Entrepreneur Stacey Bendet to Launch "Your Eggsperience Matters" Campaign to Raise Funds for RESOLVE During National Infertility Awareness Week](https://dev-gametogen.pantheonsite.io/news/gameto-partners-with-designer-and-entrepreneur-stacey-bendet-to-launch-your-eggsperience-matters-campaign-to-raise-funds-for-resolve-during-national-infertility-awareness-week/)
- [Gameto Announces FDA IND Clearance for Fertilo, the First iPSC-Based Therapy to Enter U.S. Phase 3 Clinical Trials](https://dev-gametogen.pantheonsite.io/news/gameto-announces-fda-ind-clearance-for-fertilo-the-first-ipsc-based-therapy-to-enter-u-s-phase-3-clinical-trials/)
- [Why it is key to anticipate to preserve fertility?](https://dev-gametogen.pantheonsite.io/news/por-que-es-clave-anticiparnos-para-preservar-la-fertilidad/)
- [Forbes Under 30 Healthcare 2023: Fighting Cancer, Expanding Access To Care And Protecting Women's Health](https://dev-gametogen.pantheonsite.io/news/forbes-under-30-healthcare-2023-fighting-cancer-expanding-access-to-care-and-protecting-womens-health/)
- [New York startup raises $33M for fertility treatment based on George Church’s stem cell research](https://dev-gametogen.pantheonsite.io/news/new-york-startup-raises-33m-for-fertility-treatment-based-on-george-churchs-stem-cell-research/)
- [Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University](https://dev-gametogen.pantheonsite.io/news/gameto-licenses-wyss-institutes-technology-for-growing-human-ovaries-from-harvard-university/)
- [Gameto lands ARPA-H funding to combat menopause with cell therapy](https://dev-gametogen.pantheonsite.io/news/gameto-lands-arpa-h-funding-to-combat-menopause-with-cell-therapy/)
- [Exclusive: Fertility startup to begin Phase 3 study of stem cell therapy for IVF](https://dev-gametogen.pantheonsite.io/news/exclusive-fertility-startup-to-begin-phase-3-study-of-stem-cell-therapy-for-ivf/)
- [IVF Can Be an Ordeal. Finally, Science Has a Better Way.](https://dev-gametogen.pantheonsite.io/news/ivf-can-be-an-ordeal-finally-science-has-a-better-way/)
- [Gameto lands $33 million to advance women’s reproductive health](https://dev-gametogen.pantheonsite.io/news/gameto-lands-33-million-to-advance-womens-reproductive-health/)
- [Why biology is catalyzing breakthroughs in women’s health](https://dev-gametogen.pantheonsite.io/news/why-biology-is-catalyzing-breakthroughs-in-womens-health/)
- [Is it Time to Cancel Menopause?](https://dev-gametogen.pantheonsite.io/news/is-it-time-to-cancel-menopause/)
- [Gameto, the startup that seeks to delay menopause, lands in Spain](https://dev-gametogen.pantheonsite.io/news/gameto-la-startup-que-busca-retrasar-la-menopausia-aterriza-en-espana/)
- [Why aren’t VCs funding more startups focused on menopause?](https://dev-gametogen.pantheonsite.io/news/why-arent-vcs-funding-more-startups-focused-on-menopause/)
- [International Women’s Day: the wonderful women of longevity](https://dev-gametogen.pantheonsite.io/news/international-womens-day-the-wonderful-women-of-longevity/)
- [Gameto inks stem cell deal with Reprocell for female fertility program](https://dev-gametogen.pantheonsite.io/news/gameto-inks-stem-cell-deal-with-reprocell-for-female-fertility-program/)
- [Biotech Startup Gameto on Female Fertility and Aging](https://dev-gametogen.pantheonsite.io/news/biotech-startup-gameto-on-female-fertility-and-aging/)
- [What if We Could Get Rid of Menopause?](https://dev-gametogen.pantheonsite.io/news/what-if-we-could-get-rid-of-menopause/)
- [Inception Fertility Partners with Leading Technology Companies on Breakthrough Studies to Advance Reproductive Medicine](https://dev-gametogen.pantheonsite.io/news/inception-fertility-partners-with-leading-technology-companies-on-breakthrough-studies-to-advance-reproductive-medicine/)
- [Gameto founder talks menopause and female healthspan extension](https://dev-gametogen.pantheonsite.io/news/gameto-founder-talks-menopause-and-female-healthspan-extension-copy/)
- [A Less Brutal Alternative to IVF](https://dev-gametogen.pantheonsite.io/news/a-less-brutal-alternative-to-ivf/)
- [Varsavsky chooses Madrid for the preclinical studies in Europe of his startup Gameto](https://dev-gametogen.pantheonsite.io/news/varsavsky-elige-madrid-para-los-estudios-preclinicos-en-europa-de-su-startup-gameto/)
- [Gameto Expands Executive Team with the Appointment of David McCulloh, Ph.D., H.C.L.D., C.C. as Vice President of Embryology](https://dev-gametogen.pantheonsite.io/news/gameto-expands-executive-team-with-the-appointment-of-david-mcculloh-ph-d-h-c-l-d-c-c-as-vice-president-of-embryology/) - McCulloh joins Gameto's team of former Harvard University Wyss Institute scientists as the biotech continues trials for its fertility biologic with partner clinics.
- [A healthcare brand for women begins to take shape](https://dev-gametogen.pantheonsite.io/news/a-healthcare-brand-for-women-begins-to-take-shape/)
- [This Next Generation IVF Startup Facilitated The Birth Of A Baby For The First Time](https://dev-gametogen.pantheonsite.io/news/this-next-generation-ivf-startup-facilitated-the-birth-of-a-baby-for-the-first-time/)
- [34 of the most promising women's health startups of 2022, according to VCs](https://dev-gametogen.pantheonsite.io/news/34-of-the-most-promising-womens-health-startups-of-2022-according-to-vcs/)
- [Dawn of the Silicon Valley Superbaby](https://dev-gametogen.pantheonsite.io/news/dawn-of-the-silicon-valley-superbaby/)
- [Stem Cell Podcast Ep. 281: “Fertility Treatments” Featuring Drs. Dina Radenkovic and Bruna Paulsen](https://dev-gametogen.pantheonsite.io/news/stem-cell-podcast-ep-281-fertility-treatments-featuring-drs-dina-radenkovic-and-bruna-paulsen/)
- [Gameto Raises $33M to Use Cell Engineering to Revolutionize Fertility Treatments](https://dev-gametogen.pantheonsite.io/news/gameto-raises-33m-to-use-cell-engineering-to-revolutionize-fertility-treatments/)
- [Blog Post: Fertility Treatments for the New Age](https://dev-gametogen.pantheonsite.io/news/blog-post-fertility-treatments-for-the-new-age/)
- [Gameto Announces Path Towards a U.S. Phase 3 Trial and Executive and Advisor Appointments](https://dev-gametogen.pantheonsite.io/news/gameto-announces-path-towards-a-u-s-phase-3-trial-and-executive-and-advisor-appointments/) - Company on path towards initiating Phase 3 trials for BLA approval pending completion of specific assay and manufacturing requirements Carlos Lejtik, M.D., to lead clinical adoption and medical teams as Medical Director Pietro Bortoletto, M.D., M.Sc., and Michel de Vos, M.D., Ph.D., join as scientific and clinical advisors
- [An integrated pipeline for mammalian genetic screening](https://dev-gametogen.pantheonsite.io/news/an-integrated-pipeline-for-mammalian-genetic-screening/)
- [Gameto Presents Advances in Assisted Reproductive Technology at 2024 European Society of Human Reproduction and Embryology Annual Meeting](https://dev-gametogen.pantheonsite.io/news/gameto-presents-advances-in-assisted-reproductive-technology-at-2024-european-society-of-human-reproduction-and-embryology-annual-meeting/) - Gameto’s innovative technology demonstrates in vitro egg maturation mirrors natural gene expression Poster results presented at 2024 European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting

## Publications

- [Initiation of meiosis from human iPSCs under defined conditions through identification of regulatory factors](https://dev-gametogen.pantheonsite.io/publications/initiation-of-meiosis-from-human-ipscs-under-defined-conditions-through-identification-of-regulatory-factors/) - Meiotic failure is a major cause of infertility, but the lack of an in vitro model of human meiosis is a barrier to understanding its mechanism. Here, we establish a method to initiate meiosis directly from male or female human-induced pluripotent stem cells (iPSCs).
- [Development of human induced pluripotent stem cell-derived ovarian support cells as a clinical-grade product for in vitro fertilization](https://dev-gametogen.pantheonsite.io/publications/development-of-human-induced-pluripotent-stem-cell-derived-ovarian-support-cells-as-a-clinical-grade-product-for-in-vitro-fertilization/)
- [Translation of a human induced pluripotent stem cell-derived ovarian support cell product to a Phase 3 enabling clinical grade product for in vitro fertilization treatment](https://dev-gametogen.pantheonsite.io/publications/translation-of-a-human-induced-pluripotent-stem-cell-derived-ovarian-support-cell-product-to-a-phase-3-enabling-clinical-grade-product-for-in-vitro-fertilization-treatment/)
- [Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment](https://dev-gametogen.pantheonsite.io/publications/donor-side-effects-experienced-under-minimal-controlled-ovarian-stimulation-cos-with-in-vitro-maturation-ivm-versus-conventional-cos-for-in-vitro-fertilization-ivf-treatment/)
- [Human-induced pluripotent stem cell-derived ovarian support cell co-culture improves oocyte maturation in vitro after abbreviated gonadotropin stimulation](https://dev-gametogen.pantheonsite.io/publications/human-reproduction-publication/) - Study conducted in partnership with Spring Fertility, Extend Fertility, and Eugin Group assessed the maturation rate and embryo formation of oocytes collected from 67 participants who underwent up to three days of gonadotropin stimulation prior to egg retrieval.
- [Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression](https://dev-gametogen.pantheonsite.io/publications/directed-differentiation-of-human-ipscs-to-functional-ovarian-granulosa-like-cells-via-transcription-factor-overexpression/) - Study conducted in partnership with the George Church Lab at The Wyss Institute of Harvard Medical School describes a novel protocol to generate granulosa-like cells through targeted transcription factor overexpression.
- [Towards reconstituting an ovary](https://dev-gametogen.pantheonsite.io/publications/towards-reconstituting-an-ovary/)
- [Road to in vitro maturation (IVM), from basic science to an informed clinical practice](https://dev-gametogen.pantheonsite.io/publications/road-to-in-vitro-maturation-ivm-from-basic-science-to-an-informed-clinical-practice/)
- [Rescue in vitro maturation using ovarian support cells of human oocytes from conventional stimulation cycles yields oocytes with improved nuclear maturation and transcriptomic resemblance to in vivo matured oocytes](https://dev-gametogen.pantheonsite.io/publications/rescue-in-in-vitro-maturation-using-ovarian-support-cells-of-human-oocytes-from-conventional-stimulation-cycles-yields-oocytes-with-improved-nuclear-maturation-and-transcriptomic-resemblance-to-in-viv/)
- [Rapid human oogonia-like cell specification via transcription factor-directed differentiation](https://dev-gametogen.pantheonsite.io/publications/rapid-human-oogonia-like-cell-specification-via-transcription-factor-directed-differentiation/)
- [Ovarian support cell in vitro maturation (OSC-IVM) results in healthy murine live births with no evidence of reprotoxicology in a multigenerational study](https://dev-gametogen.pantheonsite.io/publications/ovarian-support-cell-in-vitro-maturation-osc-ivm-results-in-healthy-murine-live-births-with-no-evidence-of-reprotoxicology-in-a-multigenerational-study/)
- [Improved rescue of immature oocytes obtained from conventional gonadotropin stimulation cycles via human induced pluripotent stem cell-derived ovarian support cell co-culture](https://dev-gametogen.pantheonsite.io/publications/improved-rescue-of-immature-oocytes-obtained-from-conventional-gonadotropin-stimulation-cycles-via-human-induced-pluripotent-stem-cell-derived-ovarian-support-cell-co-culture/)
- [Expanding homogeneous culture of human primordial germ cell-like cells maintaining germline features without serum or feeder layers](https://dev-gametogen.pantheonsite.io/publications/expanding-homogeneous-culture-of-human-primordial-germ-cell-like-cells-maintaining-germline-features-without-serum-or-feeder-layers/)
- [Efficient Human Germ Cell Specification from Stem Cells via Combinatorial Expression of Transcription Factors](https://dev-gametogen.pantheonsite.io/publications/efficient-human-germ-cell-specification-from-stem-cells-via-combinatorial-expression-of-transcription-factors/)
- [Clinical procedures for in vitro maturation treatment](https://dev-gametogen.pantheonsite.io/publications/clinical-procedures-for-in-vitro-maturation-treatment/)
- [An integrated pipeline for mammalian genetic screening](https://dev-gametogen.pantheonsite.io/publications/an-integrated-pipeline-for-mammalian-genetic-screening/)
- [Reproducible differentiation of pure ovarian support cells from clinical-grade hiPSCs as a novel infertility treatment](https://dev-gametogen.pantheonsite.io/publications/reproducible-differentiation-of-pure-ovarian-support-cells-from-clinical-grade-hipscs-as-a-novel-infertility-treatment/)

## News Categories

- [News](https://dev-gametogen.pantheonsite.io/newsroom/news/)
- [Scientific Publications](https://dev-gametogen.pantheonsite.io/newsroom/scientific-publication/)
- [Press Releases](https://dev-gametogen.pantheonsite.io/newsroom/press-releases/)